Document is current
Any future updates will be listed below
-
Authors
Page, Courtney L.
Holbrook, Beth C.
Crofts, Kali F.
Alameh, Mohamad-Gabriel
Davis, Benjamin
Caudell, David
Weissman, Drew
Alexander-Miller, Martha A.
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (CIVICS Option 22B)
- License Information
-
More Information
Article History
Received: 10 June 2025
Accepted: 7 November 2025
First Online: 26 December 2025
Competing interests
: In accordance with the University of Pennsylvania policies and procedures and our ethical obligations as researchers, we report that Dr. Drew Weissman is named on patents that describe the use of nucleoside-modified mRNA as a platform to deliver therapeutic proteins and vaccines. We have disclosed those interests fully to the University of Pennsylvania, and we have in place an approved plan for managing any potential conflicts arising from licensing of our patents. The authors have no additional financial interests.
